93 related articles for article (PubMed ID: 25099619)
1. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
Lee YY; Li CF; Lin CY; Lee SW; Sheu MJ; Lin LC; Chen TJ; Wu TF; Hsing CH
Tumour Biol; 2014 Nov; 35(11):11097-105. PubMed ID: 25099619
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.
Lee YY; Wei YC; Tian YF; Sun DP; Sheu MJ; Yang CC; Lin LC; Lin CY; Hsing CH; Li WS; Li CF; Hsieh PL; Lin CY
J Cancer; 2017; 8(8):1330-1337. PubMed ID: 28638446
[No Abstract] [Full Text] [Related]
3. Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy.
Su YT; Chen CH; Kang JW; Kuo HY; Yang CC; Tian YF; Yeh CF; Chou CL; Chen SH
Aging (Albany NY); 2024 May; 16(9):7889-7901. PubMed ID: 38709264
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.
Chiang SF; Huang KC; Chen WT; Chen TW; Ke TW; Chao KSC
Cancer Immunol Immunother; 2021 Oct; 70(10):2937-2950. PubMed ID: 33713152
[TBL] [Abstract][Full Text] [Related]
5. Identification of unique rectal cancer-specific subtypes.
Kisakol B; Matveeva A; Salvucci M; Kel A; McDonough E; Ginty F; Longley DB; Prehn JHM
Br J Cancer; 2024 May; 130(11):1809-1818. PubMed ID: 38532103
[TBL] [Abstract][Full Text] [Related]
6. SIRT5 regulation of ammonia-induced autophagy and mitophagy.
Polletta L; Vernucci E; Carnevale I; Arcangeli T; Rotili D; Palmerio S; Steegborn C; Nowak T; Schutkowski M; Pellegrini L; Sansone L; Villanova L; Runci A; Pucci B; Morgante E; Fini M; Mai A; Russo MA; Tafani M
Autophagy; 2015; 11(2):253-70. PubMed ID: 25700560
[TBL] [Abstract][Full Text] [Related]
7. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
Kim J; Hu Z; Cai L; Li K; Choi E; Faubert B; Bezwada D; Rodriguez-Canales J; Villalobos P; Lin YF; Ni M; Huffman KE; Girard L; Byers LA; Unsal-Kacmaz K; Peña CG; Heymach JV; Wauters E; Vansteenkiste J; Castrillon DH; Chen BPC; Wistuba I; Lambrechts D; Xu J; Minna JD; DeBerardinis RJ
Nature; 2017 Jun; 546(7656):168-172. PubMed ID: 28538732
[TBL] [Abstract][Full Text] [Related]
8. Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
Çeliktas M; Tanaka I; Tripathi SC; Fahrmann JF; Aguilar-Bonavides C; Villalobos P; Delgado O; Dhillon D; Dennison JB; Ostrin EJ; Wang H; Behrens C; Do KA; Gazdar AF; Hanash SM; Taguchi A
J Natl Cancer Inst; 2017 Mar; 109(3):1-9. PubMed ID: 28376202
[TBL] [Abstract][Full Text] [Related]
9. The Study of Carbamoyl Phosphate Synthetase 1 Deficiency Sheds Light on the Mechanism for Switching On/Off the Urea Cycle.
Díez-Fernández C; Gallego J; Häberle J; Cervera J; Rubio V
J Genet Genomics; 2015 May; 42(5):249-60. PubMed ID: 26059772
[TBL] [Abstract][Full Text] [Related]
10. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J
Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153
[TBL] [Abstract][Full Text] [Related]
11. A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.
Yang W; Gong X; Wang X; Huang C
Invest New Drugs; 2019 Oct; 37(5):865-875. PubMed ID: 30488243
[TBL] [Abstract][Full Text] [Related]
12. Bile acid: a potential inducer of colon cancer stem cells.
Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
[TBL] [Abstract][Full Text] [Related]
13. CPS1: Looking at an ancient enzyme in a modern light.
Nitzahn M; Lipshutz GS
Mol Genet Metab; 2020 Nov; 131(3):289-298. PubMed ID: 33317798
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.
;
Cell; 2017 Jun; 169(7):1327-1341.e23. PubMed ID: 28622513
[TBL] [Abstract][Full Text] [Related]
15. Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis.
Maekawa M; Tanaka A; Ogawa M; Roehrl MH
PLoS One; 2024; 19(5):e0302109. PubMed ID: 38696425
[TBL] [Abstract][Full Text] [Related]
16. Genetics of enzymatic dysfunctions in metabolic disorders and cancer.
Mahé M; Rios-Fuller TJ; Karolin A; Schneider RJ
Front Oncol; 2023; 13():1230934. PubMed ID: 37601653
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of electroacupuncture and herb-partitioned moxibustion on ulcerative colitis animal model: A study based on proteomics.
Qi Q; Zhong R; Liu YN; Zhao C; Huang Y; Lu Y; Ma Z; Zheng HD; Wu LY
World J Gastroenterol; 2022 Jul; 28(28):3644-3665. PubMed ID: 36161055
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Serum Urea, Creatinine and Uric Acid in Oral Cancer.
Caruntu A; Moraru L; Ciubotaru DA; Tanase C; Scheau C; Caruntu C
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743528
[TBL] [Abstract][Full Text] [Related]
19. The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes.
Seborova K; Kloudova-Spalenkova A; Koucka K; Holy P; Ehrlichova M; Wang C; Ojima I; Voleska I; Daniel P; Balusikova K; Jelinek M; Kovar J; Rob L; Hruda M; Mrhalova M; Soucek P; Vaclavikova R
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008510
[TBL] [Abstract][Full Text] [Related]
20. A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer.
Peng W; Lin C; Jing S; Su G; Jin X; Di G; Shao Z
Front Oncol; 2021; 11():746763. PubMed ID: 34604089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
